2 completed, 2 unknown, 1 withdrawn. 2 Phase 3, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Iris Sommer: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder Raloxifene, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 3 | Completed | Iris Sommer | 110 | 2016-08-01 | 2021-10-08 |
| Transcranial Direct Current Stimulation as Treatment for Auditory Hallucinations Eldith DC Stimulator stimulation, Eldith DC Stimulator sham stimulation - Psychotic Disorders, Mood Disorders | Not applicable | Unknown | Iris Sommer | 62 | 2014-04-01 | 2017-05-03 |
| Understanding Hallucinations (Part II) Hallucinations | Unknown | Iris Sommer | 240 | 2013-11-01 | 2016-10-26 | |
| Simvastatin Addition for Patients With Recent-onset Schizophrenia Simvastatin, Placebo - Schizophrenia, Schizoaffective Disorder | Phase 3 | Completed | Iris Sommer | 121 | 2013-10-01 | 2020-10-19 |
| Effect of Methylphenidate on Connectivity Methylphenidate, Placebo - Attention Deficit Hyperactivity Disorder | Phase 4 | Withdrawn | Iris Sommer | 2013-04-01 | 2014-02-26 |
Psychotic Disorders (3) · Mental Disorders (2) · Schizophrenia (2) · Attention Deficit Disorder with Hyperactivity (1) · Hallucinations (1) · Hearing Disorders (1) · Mood Disorders (1) · Personality Disorders (1) · Stress Disorders, Post-Traumatic (1)
Methylphenidate (1) · Raloxifene Hydrochloride (1) · Simvastatin (1)
Netherlands (5)
Bob Oranje, Ass. Prof. (1) · Iris EC Sommer, Prof, Dr. (1) · Iris EC Sommer, Prof. dr. (1) · Janna de Boer, MD (1)
PMID 26674520, PMID 29934249, PMID 34078485, PMID 38377869
2015 (1)